pioglitazone
pioglitazone is listed in the FDA National Drug Code directory with 6 NDC codes, marketed under brand name including Actos. Available dosage form: tablet.
Drug Details
- Generic Name
- pioglitazone
- Brand Names
- Actos
- Application Number
- NDA021073
- Sponsor
- Takeda Pharmaceutical Company Limited
- NDC Codes
- 6
- Dosage Forms
- TABLET
- Routes
- ORAL
- Active Ingredients
- PIOGLITAZONE HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE Pioglitazone and metformin hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use Pioglitazone and metformin hydrochloride tablets are not recommended to treat type 1 diabetes mellitus or diabetic ketoacidosis. Pioglitazone and metformin hydrochloride tablets are a combination of pioglitazone, a thiazolidinedione agonist of peroxisome proliferator receptor gamma, and metformin hydrochloride, a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1 ) Limitations of Use: Not recommended for treatment of type 1 diabetes or diabetic ketoacidosis. ( 1 )